Lourdes Ceron-Gutierrez
Overview
Explore the profile of Lourdes Ceron-Gutierrez including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
2911
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Griffin H, Ceron-Gutierrez L, Gharahdaghi N, Ebrahimi S, Davies S, Loo P, et al.
N Engl J Med
. 2024 Jul;
391(5):434-441.
PMID: 39083772
We discovered high-titer neutralizing autoantibodies against interleukin-10 in a child with infantile-onset inflammatory bowel disease (IBD), a phenocopy of inborn errors of interleukin-10 signaling. After B-cell-depletion therapy and an associated...
2.
Ferreira I, Lee C, Foster W, Abdullahi A, Dratva L, Tuong Z, et al.
Cell Rep
. 2023 Aug;
42(8):112991.
PMID: 37590132
Suboptimal responses to a primary vaccination course have been reported in the elderly, but there is little information regarding the impact of age on responses to booster third doses. Here,...
3.
Yam-Puc J, Hosseini Z, Horner E, Pereyra Gerber P, Beristain-Covarrubias N, Hughes R, et al.
Nat Commun
. 2023 Jun;
14(1):3292.
PMID: 37369658
Age-associated B cells (ABC) accumulate with age and in individuals with different immunological disorders, including cancer patients treated with immune checkpoint blockade and those with inborn errors of immunity. Here,...
4.
van der Klaauw A, Horner E, Pereyra-Gerber P, Agrawal U, Foster W, Spencer S, et al.
Nat Med
. 2023 May;
29(5):1146-1154.
PMID: 37169862
Obesity is associated with an increased risk of severe Coronavirus Disease 2019 (COVID-19) infection and mortality. COVID-19 vaccines reduce the risk of serious COVID-19 outcomes; however, their effectiveness in people...
5.
Kemp S, Collier D, Datir R, Ferreira I, Gayed S, Jahun A, et al.
Nature
. 2022 Jul;
608(7922):E23.
PMID: 35864233
No abstract available.
6.
Collier D, De Marco A, Ferreira I, Meng B, Datir R, Walls A, et al.
Nature
. 2022 Jul;
608(7922):E24.
PMID: 35864232
No abstract available.
7.
Meng B, Abdullahi A, Ferreira I, Goonawardane N, Saito A, Kimura I, et al.
Nature
. 2022 Feb;
603(7902):706-714.
PMID: 35104837
The SARS-CoV-2 Omicron BA.1 variant emerged in 2021 and has multiple mutations in its spike protein. Here we show that the spike protein of Omicron has a higher affinity for...
8.
Colombo S, Hashad R, Denning D, Kumararatne D, Ceron-Gutierrez L, Barcenas-Morales G, et al.
J Infect Dis
. 2021 Dec;
225(10):1822-1831.
PMID: 34850023
Background: Immune defects in chronic pulmonary aspergillosis (CPA) are poorly characterized. We compared peripheral blood cytokine profiles in patients with CPA versus healthy controls and explored the relationship with disease...
9.
Baxendale H, Wells D, Gronlund J, Nadesalingham A, Paloniemi M, Carnell G, et al.
J Crit Care Med (Targu Mures)
. 2021 Nov;
7(3):199-210.
PMID: 34722923
Introduction: In early 2020, at first surge of the coronavirus disease 2019 (COVID-19) pandemic, many health care workers (HCW) were re-deployed to critical care environments to support intensive care teams...
10.
Collier D, Ferreira I, Kotagiri P, Datir R, Lim E, Touizer E, et al.
Nature
. 2021 Jun;
596(7872):417-422.
PMID: 34192737
Although two-dose mRNA vaccination provides excellent protection against SARS-CoV-2, there is little information about vaccine efficacy against variants of concern (VOC) in individuals above eighty years of age. Here we...